IAPP and type 2 diabetes mellitus: Despite the existing evidence for amylin oligomerization in the brains of T2DM and AD patients (Jackson et al., 2013), it remains controversial whether this neuropathological effect can be related to, or even induced by, alterations in peripheral amylin homeostasis.